Advanced Search
REVIEW ARTICLE
Korean J Pediatr 2012 November;55(11) :403-407.
Published online 2012 August 18.        doi:https://doi.org/10.3345/kjp.2012.55.11.403
Understanding noninferiority trials
Seokyung Hahn (Hahn SK)
Department of Medicine, Seoul National University College of Medicine, Seoul, Division of Medical Statistics, Medical Research Collaborating Center, Seoul National University Hospital, Seoul, Korea
Corresponding Author: Seokyung Hahn ,Tel: +82-2-740-8911, Fax: +82-2-743-8361, Email: hahns@snu.ac.kr
Copyright © 2012 by The Korean Pediatric Society
ABSTRACT
Noninferiority trials test whether a new experimental treatment is not unacceptably less efficacious than an active control treatment already in use. With continuous improvements in health technologies, standard care, and clinical outcomes, the incremental benefits of newly developed treatments may be only marginal over existing treatments. Sometimes assigning patients to a placebo is unethical. In such circumstances, there has been increasing emphasis on the use of noninferiority trial designs. Noninferiority trials are more complex to design, conduct, and interpret than typical superiority trials. This paper reviews the concept of noninferiority trials and discusses some important issues related to them.
Keywords: Noninferiority trial | Controlled clinical trials | Randomized controlled clinical trials | Clinical trials
 
REFERENCE
0. emea.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003658.pdf
0. emea.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003636.pdf
0. hhs.gov/asl/testify/2012/04/t20120418a.html
1. Rosato R, Ciccone G, Bo S, Pagano GF, Merletti F, Gregori D. Evaluating cardiovascular mortality in type 2 diabetes patients: an analysis based on competing risks Markov chains and additive regression models. J Eval Clin Pract 2007;13:422–428.
2. Stephan BC, Kurth T, Matthews FE, Brayne C, Dufouil C. Dementia risk prediction in the population: are screening models accurate?. Nat Rev Neurol 2010;6:318–326.
3. Temple R, Ellenberg SS. Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 1: ethical and scientific issues. Ann Intern Med 2000;133:455–46
4. Ellenberg SS, Temple R. Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 2: practical issues and specific cases. Ann Intern Med 2000;133:464–470.
5. Freedman B. Equipoise and the ethics of clinical research. N Engl J Med 1987;317:141–14
6. D'Agostino RB Sr, Massaro JM, Sullivan LM. Non-inferiority trials: design concepts and issues - the encounters of academic consultants in statistics. Stat Med 2003;22:169–18
7. Gotzsche PC. Lessons from and cautions about noninferiority and equivalence randomized trials. JAMA 2006;295:1172–1174.
8. Jones B, Jarvis P, Lewis JA, Ebbutt AF. Trials to assess equivalence: the importance of rigorous methods. BMJ 1996;313:36–39.
9. Pocock SJ. The pros and cons of noninferiority trials. Fundam Clin Pharmacol 2003;17:483–490.
10. European Medicines AgencyCommittee for proprietary medicinal products (CPMP) [Internet]. London: European Medicines Agency; c2012 [cited 2012 Jun 5].
11. European Medicines AgencyGuideline on the choice of the noninferiority margin [Internet]. London: European Medicines Agency; c2012 [cited 2012 Jun 5].
12. U.S. Department of Health and Human ServicesFood and Drug AdministrationCenter for Drug Evaluation and Research (CDER)Center for Biologics Evaluation and Research (CBER)Guidance for Industry, non-inferiority clinical trials [Internet]. Washington: U.S. Department of Health and Human Services; c2012 [cited 2012 Jun 5].
13. Piaggio G, Elbourne DR, Altman DG, Pocock SJ, Evans SJ. CONSORT Group. Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement. JAMA 2006;295:1152–1160.
TOOLS
PDF Links  PDF Links
Full text via DOI  Full text via DOI
  via Pubmed
Full text via PMC  Full text via PMC
via Pubreader  via PubReader
Download Citation  Download Citation
Supplementary Material  Supplementary Material
  E-Mail
Share:      
METRICS
1,414
View
27
Download
Register for e-submission
Register here to access the e-submission system of Korean J Pediatr for authors and reviewers.
Manuscript Submission
To submit a manuscript, please visit the Korean J Pediatr e-submission management system at http://submit.kjp.or.kr, read the Instructions for Authors, and log into the Korean J Pediatr e-submission system. For assistance with manuscript submission, please contact: kjpped@gmail.com.
Free archive
Anyone may access any past or current articles without logging in.
Korean Pediatric Society Office
#1606, Seocho World Officetel, 19 Seoun-ro, Seocho-gu, Seoul 137-070, Korea
TEL : +82-2-3473-7305    FAX : +82-2-3473-7307   E-mail: kjpped@gmail.com
BrowseCurrent IssueFor Authors and ReviewersAbout
Copyright© The Korean Pediatric Society. All right reserved.